Hepatitis B Reactivation in a Patient Receiving Chemotherapy for Breast Cancer: A Case Report

被引：4

作者：

Remo, Mylene ^{[1
]}

Abraham, Ivy ^{[1
]}

Kankanala, Vineel ^{[2
]}

Chacra, Wadih ^{[2
]}

Danciu, Oana C. ^{[1
]}

机构：

[1] Univ Illinois, Coll Med, Div Hematol Oncol, 840 South Wood St,Room 832,MC 713, Chicago, IL 60612 USA

[2] Univ Illinois, Coll Med, Div Gastroenterol & Hepatol, Chicago, IL USA

来源：

ANTICANCER RESEARCH | 2017年 / 37卷 / 07期

关键词：

Breast cancer; chemotherapy; hepatitis B; liver failure; screening; VIRUS REACTIVATION; MANAGEMENT; PREVENTION;

D O I：

10.21873/anticanres.11755

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Hepatitis B virus (HBV) reactivation is a known complication of immunosuppressive therapy. While patients who are undergoing treatment with anti-CD20 agents or stem cell transplantation are commonly screened for chronic HBV infection prior to treatment, there are no consensus guidelines regarding HBV screening for patients undergoing chemotherapy for solid tumors. We present a rare case of fulminant liver failure due to HBV reactivation in a patient receiving chemotherapy for breast cancer. Our case highlights the importance of developing definitive guidelines regarding HBV screening in patients receiving chemotherapy for solid tumors and raises the question of the need for universal screening.

引用

页码：3791 / 3793

页数：3

共 50 条

[1] Hepatitis B Reactivation in Patients Receiving Chemotherapy for Lymphoma or Breast Cancer
Saumoy, Monica
Schneider, Yecheskel
Schwartz, Robert
Kumar, Sonal
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S907 - S907
[2] Reactivation of hepatitis in a bladder cancer patient receiving chemotherapy receiving chemotherapy
Higashiyama, Hiroshi
Harabayashi, Toru
Shinohara, Nobuo
Chuma, Makoto
Hige, Shuhei
Nonomura, Katsuya
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2007, 39 (02) : 461 - 463
[3] Reactivation of Hepatitis in a Bladder Cancer Patient Receiving Chemotherapy
Hiroshi Higashiyama
Toru Harabayashi
Nobuo Shinohara
Makoto Chuma
Shuhei Hige
Katsuya Nonomura
International Urology and Nephrology, 2007, 39 : 461 - 463
[4] Management of hepatitis B reactivation in patients receiving cancer chemotherapy
Huang, Yi-Wen
Chung, Raymond T.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2012, 5 (05) : 359 - 370
[5] Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: A prospective study
Yeo, W
Chan, PKS
Hui, P
Ho, WM
Lam, KC
Kwan, WH
Zhong, S
Johnson, PJ
JOURNAL OF MEDICAL VIROLOGY, 2003, 70 (04) : 553 - 561
[6] Hepatitis B virus reactivation in adjuvant chemotherapy for breast cancer
Ide, Yoshimi
Ito, Yoshinori
Takahashi, Shunji
Tokudome, Nahomi
Kobayashi, Kokoro
Sugihara, Tsutomu
Hattori, Masaya
Yokoyama, Masahiro
Uchiyama, Akira
Inoue, Kazuaki
Sakurai, Norio
Hatake, Kiyohiko
BREAST CANCER, 2013, 20 (04) : 367 - 370
[7] Hepatitis B virus reactivation in adjuvant chemotherapy for breast cancer
Yoshimi Ide
Yoshinori Ito
Shunji Takahashi
Nahomi Tokudome
Kokoro Kobayashi
Tsutomu Sugihara
Masaya Hattori
Masahiro Yokoyama
Akira Uchiyama
Kazuaki Inoue
Norio Sakurai
Kiyohiko Hatake
Breast Cancer, 2013, 20 : 367 - 370
[8] Fatal hepatitis B reactivation in a patient receiving chemoradiation for cervical cancer
Dimond, Colin
Negroiu, Andreea
M. Hughes, David
Patel, Jasmine
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (05) : 1296 - 1301
[9] Reactivation of Hepatitis B Virus in Patients Receiving Chemotherapy
Ikeda, Masafumi
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (01) : 8 - 16
[10] Entecavir is Effective in Preventing Hepatitis B Reactivation in Cancer Patients Receiving Chemotherapy
Mendelsohn, Robin B.
Taur, Ying
Ng, Garen
Patel, Dhruv
Kamboj, Mini
Zelenetz, Andrew D.
Sepkovritz, Kent
Ludwig, Emmy
GASTROENTEROLOGY, 2011, 140 (05) : S930 - S930

← 1 2 3 4 5 →